Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Dengue virus antibodies enhance Zika virus infection.

Paul LM, Carlin ER, Jenkins MM, Tan AL, Barcellona CM, Nicholson CO, Michael SF, Isern S.

Clin Transl Immunology. 2016 Dec 16;5(12):e117. doi: 10.1038/cti.2016.72. eCollection 2016 Dec.

2.

DO-RIP-seq to quantify RNA binding sites transcriptome-wide.

Nicholson CO, Friedersdorf MB, Bisogno LS, Keene JD.

Methods. 2017 Apr 15;118-119:16-23. doi: 10.1016/j.ymeth.2016.11.004. Epub 2016 Nov 10.

3.

Quantifying RNA binding sites transcriptome-wide using DO-RIP-seq.

Nicholson CO, Friedersdorf M, Keene JD.

RNA. 2017 Jan;23(1):32-46. Epub 2016 Oct 14.

4.

SHAPE reveals transcript-wide interactions, complex structural domains, and protein interactions across the Xist lncRNA in living cells.

Smola MJ, Christy TW, Inoue K, Nicholson CO, Friedersdorf M, Keene JD, Lee DM, Calabrese JM, Weeks KM.

Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):10322-7. doi: 10.1073/pnas.1600008113. Epub 2016 Aug 30.

5.

Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG.

Tomaras GD, Ferrari G, Shen X, Alam SM, Liao HX, Pollara J, Bonsignori M, Moody MA, Fong Y, Chen X, Poling B, Nicholson CO, Zhang R, Lu X, Parks R, Kaewkungwal J, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, Gilbert PB, Kim JH, Michael NL, Montefiori DC, Haynes BF.

Proc Natl Acad Sci U S A. 2013 May 28;110(22):9019-24. doi: 10.1073/pnas.1301456110. Epub 2013 May 9.

6.

Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop.

Costin JM, Zaitseva E, Kahle KM, Nicholson CO, Rowe DK, Graham AS, Bazzone LE, Hogancamp G, Figueroa Sierra M, Fong RH, Yang ST, Lin L, Robinson JE, Doranz BJ, Chernomordik LV, Michael SF, Schieffelin JS, Isern S.

J Virol. 2013 Jan;87(1):52-66. doi: 10.1128/JVI.02273-12. Epub 2012 Oct 17.

7.

Viral entry inhibitors block dengue antibody-dependent enhancement in vitro.

Nicholson CO, Costin JM, Rowe DK, Lin L, Jenwitheesuk E, Samudrala R, Isern S, Michael SF.

Antiviral Res. 2011 Jan;89(1):71-4. doi: 10.1016/j.antiviral.2010.11.008. Epub 2010 Nov 18.

PMID:
21093488
8.

Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient.

Schieffelin JS, Costin JM, Nicholson CO, Orgeron NM, Fontaine KA, Isern S, Michael SF, Robinson JE.

Virol J. 2010 Feb 4;7:28. doi: 10.1186/1743-422X-7-28.

Supplemental Content

Loading ...
Support Center